Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine

NCT00294385 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

430

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Docetaxel
DRUG: Gemcitabine, Docetaxel
DRUG: Docetaxel

Sponsor

Central European Cooperative Oncology Group